SCHEMBL7697050

SCHEMBL7697050

Clc1cccc(SCc2nc3cc4ccccc4cc3nc2CSc2cccc(Cl)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALPG P10696 1/20 0.44
MAOB P27338 2/20 0.41
MAOA P21397 1/20 0.41
GRM5 P41594 1/20 0.41
DHFR P00374 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2C9 P11712 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
NQO2 P16083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697719 0.84 NPC1 (0.50) TDP1MAPTL3MBTL1MEN1KMT2A
SCHEMBL7698454 0.83 NQO2 (0.45) TDP1MAPTL3MBTL1LMNAMEN1
SCHEMBL7695424 0.81 CYP1A2 (0.42) MAPTGRM5LMNAMEN1KMT2A
SCHEMBL7697161 0.81 MAOA (0.43) MAPTL3MBTL1MAOBMAOAGRM5
SCHEMBL7689877 0.81 SMN1; SMN2 (0.43) TDP1MAPTL3MBTL1MAOBMAOA
SCHEMBL7698500 0.78 SOD1 (0.44) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL7695317 0.77 CYP2A6 (0.39) TDP1MAPTL3MBTL1LMNACYP2C9
SCHEMBL7691393 0.76 LMNA (0.54) MAPTGAAL3MBTL1GRM5DHFR
SCHEMBL7697058 0.74 RAB9A (0.50) TDP1MAPTGAAL3MBTL1DHFR
SCHEMBL7694096 0.74 NPC1 (0.50) TDP1MAPTLMNACYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed